Insider trading

Period: 120 months Stock: PTGX Plan: Not stated × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

48 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

48 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

48 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

48 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
48 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
48 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

48 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
21 Dec 2021
PATEL DINESH V PH D President and CEO
Sold, plan not stated
$482.17K 15,000 at 32.14
3.0%
17 Aug 2021
Liu David Y Chief Scientific Officer
Sold, plan not stated
$702.89K 14,779 at 47.56
20.2%
11 Feb 2021
Sold, plan not stated
$92.83K 3,700 at 25.09
100%
Sold half or more
10 Feb 2021
Sold, plan not stated 2×
$119.72K 4,700 at 25.47
100%
Sold half or more
19 Jan 2021
PATEL DINESH V PH D President and CEO
Sold, plan not stated
$611.10K 24,846 at 24.60
5.5%
11 Aug 2020
Sold, plan not stated
$42.95K 2,499 at 17.19
100%
Sold half or more
12 Mar 2020
SELICK HAROLD E Director
Bought
$80.40K 12,000 at 6.70
363%
First buy on file
3 Dec 2019
PATEL DINESH V PH D President and CEO
Bought 2×
$168.50K 30,000 at 5.62
7.9%
First buy on file
3 Dec 2019
Gupta Suneel EVP Clinical Operations
Bought
$153.90K 30,000 at 5.13
154%
First buy on file
3 Dec 2019
Giraudo Bryan Director · indirect
Bought
$45.62K 8,000 at 5.70
opened
First buy on file
3 Dec 2019
Kalkofen Donald A. Chief Financial Officer
Bought 2×
$5.99K 1,175 at 5.10
opened
First buy on file
6 Aug 2019
PATEL DINESH V PH D President and CEO
Sold, plan not stated
$95.54K 10,792 at 8.85
2.8%
6 Aug 2019
Liu David Y Chief Scientific Officer
Sold, plan not stated
$30.04K 3,395 at 8.85
6.4%
1 Mar 2019
PATEL DINESH V PH D President and CEO
Sold, plan not stated
$17.53K 2,183 at 8.03
0.6%
1 Mar 2019
Liu David Y Chief Scientific Officer
Sold, plan not stated
$6.50K 810 at 8.03
1.6%
1 Mar 2019
Shames Richard S. Chief Medical Officer
Sold, plan not stated
$5.28K 657 at 8.03
2.0%
6 Feb 2019
PATEL DINESH V PH D President and CEO
Sold, plan not stated 2×
$84.41K 10,909 at 7.74
3.0%
6 Feb 2019
Liu David Y Chief Scientific Officer
Sold, plan not stated
$29.56K 3,821 at 7.74
9.4%
6 Feb 2019
Shames Richard S. Chief Medical Officer
Sold, plan not stated 2×
$21.51K 2,778 at 7.74
10.3%
17 May 2018
CANAAN X L.P. 10% owner
Sold, plan not stated
$237.36K 38,968 at 6.09
1.8%
16 May 2018
CANAAN X L.P. 10% owner
Sold, plan not stated
$190.07K 29,441 at 6.46
1.3%
15 May 2018
CANAAN X L.P. 10% owner
Sold, plan not stated
$374.08K 57,715 at 6.48
2.6%
14 May 2018
CANAAN X L.P. 10% owner
Sold, plan not stated
$494.22K 77,591 at 6.37
3.3%
23 Mar 2018
CANAAN X L.P. 10% owner
Sold, plan not stated
$1.24M 59,950 at 20.71
2.5%
22 Mar 2018
CANAAN X L.P. 10% owner
Sold, plan not stated
$98.13K 4,759 at 20.62
0.2%
21 Mar 2018
CANAAN X L.P. 10% owner
Sold, plan not stated
$364.73K 17,699 at 20.61
0.7%
20 Mar 2018
CANAAN X L.P. 10% owner
Sold, plan not stated
$351.54K 17,060 at 20.61
0.7%
19 Mar 2018
CANAAN X L.P. 10% owner
Sold, plan not stated
$276.45K 13,439 at 20.57
0.6%
16 Mar 2018
CANAAN X L.P. 10% owner
Sold, plan not stated
$142.06K 6,926 at 20.51
0.3%
15 Mar 2018
CANAAN X L.P. 10% owner
Sold, plan not stated
$242.52K 11,751 at 20.64
0.5%
14 Mar 2018
CANAAN X L.P. 10% owner
Sold, plan not stated
$4.15K 200 at 20.77
0.0%
13 Mar 2018
CANAAN X L.P. 10% owner
Sold, plan not stated
$25.09K 1,204 at 20.84
0.0%
12 Mar 2018
Liu David Y Chief Scientific Officer
Sold, plan not stated
$74.50K 3,500 at 21.29
18.9%
2 Mar 2018
Liu David Y Chief Scientific Officer
Sold, plan not stated
$17.50K 875 at 20.00
6.2%
16 Jan 2018
Liu David Y Chief Scientific Officer
Sold, plan not stated
$17.50K 875 at 20.00
18.6%
22 Dec 2017
Shames Richard S. Chief Medical Officer
Sold, plan not stated
$72.34K 3,529 at 20.50
100%
Sold half or more
21 Dec 2017
PATEL DINESH V PH D President and CEO
Sold, plan not stated
$160.57K 8,210 at 19.56
4.1%
20 Dec 2017
PATEL DINESH V PH D President and CEO
Sold, plan not stated
$34.99K 1,790 at 19.55
0.9%
18 Dec 2017
O'Neil Thomas P. Chief Financial Officer
Sold, plan not stated
$160.00K 8,000 at 20.00
100%
Sold half or more
18 Dec 2017
Liu David Y Chief Scientific Officer
Sold, plan not stated
$17.50K 875 at 20.00
18.6%
30 Nov 2017
Liu David Y Chief Scientific Officer
Sold, plan not stated
$17.50K 875 at 20.00
18.6%
13 Nov 2017
Liu David Y Chief Scientific Officer
Sold, plan not stated 2×
$118.76K 7,000 at 16.97
64.7%
Sold half or more
5 Oct 2017
Shames Richard S. Chief Medical Officer
Sold, plan not stated
$38.32K 2,017 at 19.00
100%
Sold half or more
12 Sep 2017
Shames Richard S. Chief Medical Officer
Sold, plan not stated
$52.75K 3,687 at 14.31
100%
Sold half or more
29 Aug 2017
Shames Richard S. Chief Medical Officer
Sold, plan not stated
$25.70K 1,512 at 17.00
44.8%
28 Aug 2017
Liu David Y Chief Scientific Officer
Sold, plan not stated
$52.50K 3,500 at 15.00
63.6%
Sold half or more
10 Jul 2017
Liu David Y Chief Scientific Officer
Sold, plan not stated
$44.38K 3,500 at 12.68
63.6%
Sold half or more
16 May 2017
Giraudo Bryan Director
Bought
$64.57K 10,000 at 6.46
opened
First buy on file
Showing 1–48 of 48.